SC 13G: PAVmed Inc.

AI Summary

SC 13G filing by PAVmed Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class o

Filing Documents

• formsc13g.htm (SC 13G) — 110KB
• 0001493152-24-037864.txt ( ) — 111KB

From the Filing

SC 13G 1 formsc13g.htm UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. _)* PAVMED INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 70387R403 (CUSIP Number) August 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 70387R403 Schedule 13G Page 2 of 6 1 NAMES OF REPORTING PERSONS Anthony Dubreville 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 606,259 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 606,259 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 606,259 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.5% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN CUSIP No. 70387R403 Schedule 13G Page 3 of 6 1 NAMES OF REPORTING PERSONS Dubreville Family Trust 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION United NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 556,807 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 556,807 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 556,807 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.0% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO CUSIP No. 70387R403 Schedule 13G Page 4 of 6 Item 1(a). Name of Issuer: PAVmed Inc. (the “Issuer”) Item 1(b). Address of Issuer’s Principal Executive Offices: 360 Madison Avenue, 25th Floor, New York, New York 10017 Item 2(a). Name of Person Filing: This the trustee of The Dubreville Family Trust. As such, Mr. Dubreville may be deemed to have sole power to vote and dispose of the shares of the Issuer directly owned by The Dubreville Family Trust. Accordingly, the 606,259 shares of Common Stock reported as beneficially owned by Mr. Dubreville includes the 556,807 shares of Common Stock beneficially owned by The Dubreville Family Trust. Item 2(b). Address of Principal Business Office or, if None, Residence: The address of the principal business office of the Reporting Persons is c/o Graubard Miller, 405 Lexington Avenue, 44 th Floor, New York, New York 10174. Item 2(c). Citizenship: Mr. Dubreville is a citizen of the United States of America. The Dubreville Family Trust is a trust formed under the laws of California. Item 2(d). Title of Class of Securities: Common Stock, par value $0.001 per share, of the Issuer (the “Common Stock”) Item 2(e). CUSIP Number: 70387R403 Item 3. If This Statement is Filed Pursuant to Rules 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) Broker or dealer registered under Section 15 of the Exchange Act; (b) Bank as defined in Section 3(a)(6) of the Exchange Act; (c) Insurance company as defined in Section 3(a)(19) of the Exchange Act; (d) Investment company registered under Section 8 of the Investment Company Act; (e) An investment adviser in accordance with Rule 13d-1(b)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(ii)(G); (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) A non-U.S. institution, in accordance with Rule 13d-1(b)(1)(ii)(J); or (k)

View Full Filing

View this SC 13G filing on SEC EDGAR